BC Week In Review | May 28, 2007
Clinical News

Aerinaze desloratadine/pseudoephedrine regulatory update

CHMP issued a positive opinion for the approval of Aerinaze, a combination of 2.5 mg desloratadine and 120 mg pseudoephedrine to treat seasonal allergic rhinitis accompanied by nasal congestion. Schering-Plough Corp. (SGP), Kenilworth, N.J.  ...
Items per page:
1 - 1 of 1